Helixmith Catalyst Calendar
Proactively evaluate Helixmith Co Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Helixmith Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 May 2021 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
20 Jan 2021 | Phase II Trial Initiation | Helixmith Co Ltd | 084990 | donaperminogene seltoplasmid | Central Nervous System | Amyotrophic Lateral Sclerosis | Clinical Trial Registry |
01 Aug 2020 | Phase III Trial Initiation | Helixmith Co Ltd | 084990 | donaperminogene seltoplasmid | Central Nervous System; Metabolic Disorders | Diabetic Neuropathic Pain; Diabetic Peripheral Neuropathy | Clinical Trial Registry |
01 Apr 2020 | Phase II Trial Completion | Helixmith Co Ltd; REYON Pharmaceutical Co Ltd | 084990; 102460 | donaperminogene seltoplasmid | Cardiovascular | Coronary Artery Disease (CAD) (Ischemic Heart Disease); Myocardial Infarction | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer